• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病并非六周就能治愈的疾病:轻度至中度克罗恩病的终身管理。

Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.

作者信息

Lichtenstein Gary R, Hanauer Stephen B, Kane Sunanda V, Present Daniel H

机构信息

University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

出版信息

Inflamm Bowel Dis. 2004 Jul;10 Suppl 2:S2-10. doi: 10.1097/00054725-200407002-00002.

DOI:10.1097/00054725-200407002-00002
PMID:15475770
Abstract

Crohn's disease is an idiopathic, chronic inflammatory disorder of the digestive tract with heterogeneous clinical presentations. Crohn's is currently not a curable disease, and patients are faced with a lifetime of recurrent disease flare-ups and remissions. Management strategies for Crohn's must therefore be targeted toward lifelong management, taking into consideration not only the short-term but also the long-term aspects of the disease. With this in mind, here we review the classifications and natural history of Crohn's disease and discuss possible predictive factors for the disease evolution in a patient. Here we also evaluate the current preferable treatment practices, based on scientifically valid research and collective clinical experience, for the management of mild to moderate Crohn's disease.

摘要

克罗恩病是一种特发性慢性消化道炎症性疾病,临床表现多样。目前克罗恩病无法治愈,患者面临疾病反复发作和缓解的一生。因此,克罗恩病的管理策略必须针对终身管理,不仅要考虑疾病的短期情况,还要考虑长期情况。考虑到这一点,我们在此回顾克罗恩病的分类和自然史,并讨论患者疾病进展的可能预测因素。我们还根据科学有效的研究和集体临床经验,评估目前治疗轻至中度克罗恩病的优选治疗方法。

相似文献

1
Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.克罗恩病并非六周就能治愈的疾病:轻度至中度克罗恩病的终身管理。
Inflamm Bowel Dis. 2004 Jul;10 Suppl 2:S2-10. doi: 10.1097/00054725-200407002-00002.
2
Mild to moderate Crohn's disease: an evidence-based treatment algorithm.轻度至中度克罗恩病:一种基于证据的治疗算法。
Drugs. 2008;68(17):2419-25. doi: 10.2165/0003495-200868170-00002.
3
Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.综述文章:轻至中度克罗恩病——确定一种新治疗方案的基础
Aliment Pharmacol Ther. 2003 Aug 1;18(3):263-77. doi: 10.1046/j.1365-2036.2003.01661.x.
4
[Treatment of Crohn's disease].[克罗恩病的治疗]
Ther Umsch. 2003 Mar;60(3):159-63. doi: 10.1024/0040-5930.60.3.159.
5
Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?轻至中度克罗恩病的初始治疗:美沙拉嗪还是布地奈德?
Rev Gastroenterol Disord. 2002;2 Suppl 2:S9-15.
6
Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: a multicentre, double-blind, randomized, parallel-group Phase II study.口服布地奈德治疗日本活动性克罗恩病患者的疗效和耐受性:一项多中心、双盲、随机、平行分组的 II 期研究。
J Crohns Colitis. 2013 Apr;7(3):239-47. doi: 10.1016/j.crohns.2012.06.006. Epub 2012 Jul 4.
7
Medical management of Crohn's disease.克罗恩病的医学治疗。
Expert Opin Pharmacother. 2011 Nov;12(16):2505-25. doi: 10.1517/14656566.2011.609556.
8
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.溃疡性结肠炎和克罗恩病女性的分娩结局以及抗炎药物治疗的药物流行病学方面
Dan Med Bull. 2011 Dec;58(12):B4360.
9
Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.布地奈德和美沙拉嗪治疗活动性克罗恩病:对生活质量影响的比较
Am J Gastroenterol. 2002 Mar;97(3):649-53. doi: 10.1111/j.1572-0241.2002.05544.x.
10
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.一项针对肿瘤坏死因子-α人源化单克隆抗体CDP571治疗依赖皮质类固醇的克罗恩病患者的随机、双盲、安慰剂对照试验。
Aliment Pharmacol Ther. 2005 Feb 15;21(4):373-84. doi: 10.1111/j.1365-2036.2005.02336.x.

引用本文的文献

1
Mucosal DNA methylome alteration in Crohn's disease: surgical and non-surgical groups.克罗恩病黏膜DNA甲基化组改变:手术组与非手术组
Front Genet. 2023 Nov 17;14:1244513. doi: 10.3389/fgene.2023.1244513. eCollection 2023.
2
Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial.认知行为疗法对疾病活动无影响,但可改善炎症性肠病亚组患者的生活质量:一项初步随机对照试验。
BMC Gastroenterol. 2015 May 2;15:54. doi: 10.1186/s12876-015-0278-2.
3
Update on the management of Crohn's disease.
克罗恩病管理的最新进展。
Curr Gastroenterol Rep. 2011 Oct;13(5):465-74. doi: 10.1007/s11894-011-0220-x.
4
Antidepressants and inflammatory bowel disease: a systematic review.抗抑郁药与炎症性肠病:一项系统综述
Clin Pract Epidemiol Ment Health. 2006 Sep 20;2:24. doi: 10.1186/1745-0179-2-24.